Madrigal Pharmaceuticals, Inc.Madrigal Pharmaceuticals, Inc.Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

Inga transaktioner
Se i superdiagram

MDGL fundamenta

Madrigal Pharmaceuticals, Inc. earnings per share and revenue

MDGL earnings per share for the last quarter are -7.38 USD whereas the estimation was -6.22 USD which accounts for -18.64% surprise. Företagets omsättning för samma period uppgår till 0.00 USD trots den uppskattade siffran 0.00 USD. Estimated earnings per share for the next quarter are -7.42 USD, and revenue is expected to reach 3.77 M USD. Also watch annual changes over time to get a bigger picture of MDGL earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning